TABLE 3.
Total cost ($) | Total life years (QALY) | Incremental cost ($) | Incremental life years (QALY) | ICER ($ per QALY) | |
---|---|---|---|---|---|
HFrEF population | |||||
Empagliflozin group | 5,501.48 | 4.27 | 827.52 | 0.15 | 5,612.06 |
Control group | 4,673.96 | 4.12 | |||
HFpEF population | |||||
Empagliflozin group | 5,916.20 | 4.96 | 1,271.27 | 0.11 | 11,312.65 |
Control group | 4,645.23 | 4.85 |